Sawhney, Jitendra PS.Ramakrishnan, SivasubramanianMadan, KushalRay, SaumitraJayagopal, P BalagopalanPrabhakaran, DorairajNair, TinyZachariah, GeevarJain, PeeyushDalal, JamshedRadhakrishnan, SitaramanChopra, ArunKalra, SanjayMehta, AshwaniPancholia, Arvind K.Kabra, Nitin K.Kahali, DhimanGhose, TapanYadav, SatyavirKerkar, PrafullaYadav, AjayRoy, DebabrataDas, Mrinal KantiBang, Vijay H.Rath, Pratap ChandraSinha, Dhurjati PrasadBanerjee, P.S.Yadav, RakeshGupta, Rajeev2025-05-092025-05-092024-03Sawhney Jitendra PS., Ramakrishnan Sivasubramanian, Madan Kushal, Ray Saumitra, Jayagopal P Balagopalan, Prabhakaran Dorairaj, Nair Tiny, Zachariah Geevar, Jain Peeyush, Dalal Jamshed, Radhakrishnan Sitaraman, Chopra Arun, Kalra Sanjay, Mehta Ashwani, Pancholia Arvind K., Kabra Nitin K., Kahali Dhiman, Ghose Tapan, Yadav Satyavir, Kerkar Prafulla, Yadav Ajay, Roy Debabrata, Das Mrinal Kanti, Bang Vijay H., Rath Pratap Chandra, Sinha Dhurjati Prasad, Banerjee P.S., Yadav Rakesh, Gupta Rajeev . CSI clinical practice guidelines for dyslipidemia management: Executive summary. Indian Heart Journal. 2024 Mar; 76(1): 6-190019-4832https://imsear.searo.who.int/handle/123456789/242759Dyslipidemias are the most important coronary artery disease (CAD) risk factor. Proper management of dyslipidemia is crucial to control the epidemic of premature CAD in India. Cardiological Society of India strived to develop consensus-based guidelines for better lipid management for CAD prevention and treatment. The executive summary provides a bird's eye-view of the CSI: Clinical Practice Guidelines for Dyslipidemia Management published in this issue of the Indian Heart Journal. The summary is focused onthe busy clinician and encourages evidence-based management of patients and high-risk individuals. The summary has serialized various aspects of lipid management including epidemiology and categorization of CAD risk. The focus is on management of specific dyslipidemias relevant to India-raised low density lipoprotein (LDL) cholesterol, non-high density lipoprotein cholesterol (non-HDL-C), apolipoproteins, triglycerides and lipoprotein(a). Drug therapies for lipid lowering (statins, non-statin drugs and other pharmaceutical agents) and lifestyle management (dietary interventions, physical activity and yoga) are summarized. Management of dyslipidemias in oft-neglected patient phenotypes-the elderly, young and children, and patients with comorbidities-stroke, peripheral arterial disease, kidney failure, posttrans- plant, HIV (Human immunodeficiency virus), Covid-19 and familial hypercholesterolemia is also pre- sented. This consensus statement is based on major international guidelines (mainly European) and expert opinion of lipid management leaders from India with focus on the dictum: earlier the better, lower the better, longer the better and together the better. These consensus guidelines cannot replace the indi- vidual clinician judgement who remains the sole arbiter in management of the patient.DyslipidemiaLDL cholesterolCSI clinical practice guidelines for dyslipidemia management: Executive summaryJournal ArticleIndiaSir Ganga Ram Hospital, New Delhi, IndiaAll India Institute of Medical Sciences, Delhi, IndiaSir Ganga Ram Hospital, New Delhi, IndiaAdvanced Medical Research Institute (Dhakuria), Kolkata, West Bengal, IndiaLakshmi Hospital, Chittur Road, Palakkad, Kerala, IndiaCentre for Chronic Disease Control, New Delhi, IndiaPRS Hospital, Trivandrum, Kerala, IndiaMother Heart Care, Mother Hospital, Thrissur, Kerala, IndiaFortis Escorts Heart Institute, New Delhi, IndiaKokilaben Hospital, Mumbai, Maharashtra, IndiaAmrita Hospital, Greater Faridabad, Haryana, IndiaFortis Escorts Hospital, Amritsar, IndiaBharti Hospital, Karnal, IndiaSir Ganga Ram Hospital, New Delhi, IndiaArihant Hospital, Indore, IndiaGandhi Medical College, Hyderabad, IndiaBM Birla Heart Institute, Kolkata, IndiaFortis Flt Lt Rajan Dhall Hospital, New Delhi, IndiaAll India Institute of Medical Sciences, Delhi, IndiaSir Ganga Ram Hospital, New Delhi, IndiaSeth G.S. Medical College & KEM Hospital, Mumbai, IndiaSir Ganga Ram Hospital, New Delhi, IndiaNH- Rabindranath Tagore International Institute of Cardiac Sciences, Kolkata, IndiaB.M. Birla Heart Research Centre and the Calcutta Medical Research Institute (CMRI), Kolkata, IndiaLilavati Hospital and Research centre, Mumbai, Maharashtra, IndiaApollo Hospital, Jubilee Hill, Hyderabad, IndiaILS Hospital, Dumdum, Kolkata, IndiaManipal Hospital, Salt Lake, Kolkata, IndiaAll India Institute of Medical Sciences, Delhi, IndiaSir Ganga Ram Hospital, New Delhi, IndiaEternal Heart Care Centre & Research Institute, Jaipur, India